Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1557939/000155793915000028/a2015q110q.htm
September 2016
September 2016
August 2016
July 2016
June 2016
June 2016
May 2016
April 2016
March 2016
February 2016
![]() | ![]() |
• | Revenue of $444.1 million, up 0.3% from the prior-year period and 4.2% on a constant currency basis |
• | Adjusted EBITDA from continuing operations1 of $165.8 million, grew 7.7% versus the prior-year period and 10.5% on a constant currency basis, achieving an Adjusted EBITDA margin of 37.3% |
• | Loss from continuing operations improved to $4.5 million compared to $47.1 million in the prior-year period |
• | Celebrated the 20th anniversary of Acelity’s revolutionary V.A.C.® Therapy technology with record level of seasonally adjusted units in use |
• | Launched two innovative product offerings: Nanova™, an advanced wound dressing enhanced by NPWT, and the industry-first iOn Healing™ mobile application designed to provide wound care clinicians with a suite of tools to improve customer support and increase productivity |
• | Won arbitration with Vital Needs (“VNI”); the arbitration panel found that KCI has no liability for any of the claims asserted by VNI |
• | Successfully amended senior secured credit facility to provide enhanced financial flexibility |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1557939/000155793915000028/a2015q110q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acelity L.P. Inc..
Acelity L.P. Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Acelity L.P. Inc. provided additional information to their SEC Filing as exhibits
CIK: 1557939
Form Type: 10-Q Quarterly Report
Accession Number: 0001557939-15-000028
Submitted to the SEC: Fri May 01 2015 9:38:23 PM EST
Accepted by the SEC: Mon May 04 2015
Period: Tuesday, March 31, 2015
Industry: Surgical And Medical Instruments And Apparatus